Ledger.Open graph →
SEC Form D · filed August 15, 2019

Werewolf Therapeutics, Inc

Offering
$57.7M
Sold
$31.6M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (13)

Marc R. Burel · Perkasie, PADirectorKyle Sale · Boise, IDDirectorArthur Dzaghgouni · Grand Cayman, Cayman IslandsExec · DirectorDrew Eldred · Boise, IDDirectorDavid Cordo · Cambridge, MAExecRandal R. Betz · Bradenton, FLDirectorMicah Johnson · Boise, IDExecPete Hartigan · San Francisco, CAExec · DirectorDavid R. Mchale · Wilton, CTDirectorMatthew J. Arciuolo · Wilton, CTDirectorRalph Woodford · Grand Cayman, Cayman IslandsDirectorWhitney Haring-Smith · Tampra, FLDirectorPatrick Baeuerle · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗